Home › Funds › ACR Alpine Capital Research, LLC › JNJ

ACR Alpine Capital Research, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

ACR Alpine Capital Research, LLC reported holding 2,131,745 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$564.4M, representing 7.67% of its reported portfolio and ranking #4 among its reported holdings. ACR Alpine Capital Research, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.13M sh
Reported value held$564.36M
Portfolio Weight7.67%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ACR Alpine Capital Research, LLC's JNJ position evolved

ACR Alpine Capital Research, LLC first disclosed a stake in JNJ in Q3 2023 at 985,489 shares (US$153.5M). The position peaked in Q3 2026 at 2,131,745 shares, worth US$564.4M. Across 13 filings, ACR Alpine Capital Research, LLC increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 2,131,745 shares valued at US$564.4M — a reduction of -14,743 shares quarter over quarter.. Notable position changes include a 55% increase in Q4 2024 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 985.49K $153.49M New
Q4 2023 1.01M $158.49M Add
Q1 2024 1.12M $177.64M Add
Q2 2024 1.18M $172.23M Add
Q3 2024 1.18M $191.95M Add
Q4 2024 1.84M $266.14M Add
Q1 2025 2.23M $369.25M Add
Q2 2025 2.23M $340.47M Hold
Q3 2025 2.23M $413.87M Hold
Q4 2025 2.24M $462.96M Hold
Q1 2026 2.16M $527.35M Reduce
Q2 2026 2.15M $545.14M Reduce
Q3 2026 2.13M $564.36M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has ACR Alpine Capital Research, LLC held JNJ?

ACR Alpine Capital Research, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ACR Alpine Capital Research, LLC's current position in JNJ?

As of Q3 2026, ACR Alpine Capital Research, LLC holds 2.13M shares of JNJ (JOHNSON & JOHNSON), valued at $564.36M, representing 7.67% of its reported portfolio and ranking #4.

Has ACR Alpine Capital Research, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), ACR Alpine Capital Research, LLC reduced its position in JNJ. The position peaked in Q3 2026 at 2.13M shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.